Implementation of a Hepatitis B Screening Program in Patients Receiving Systemic Anti-Cancer Therapy

Implementation of a Hepatitis B Screening Program in Patients Receiving Systemic Anti-Cancer Therapy

Cancer patients receiving non-endocrine therapies are at risk of hepatitis B virus (HBV) reactivation (HBVr). Guidelines recommend HBV screening prior to treatment. The Ottawa Hospital Cancer Center implemented a screening pilot for all patients receiving FOLFOX-based regimens between January and Ap...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Leigh, Ranjeeta Mallick, Stephanie Brule, Lisa Rambout, Jennifer Newton, Dominick Bossé, Curtis Cooper, Joanna Gotfrit
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Current Oncology
Subjects:
hepatitis B virus
hepatitis B viral reactivation
gastrointestinal cancer
colorectal cancer
screening
Online Access:https://www.mdpi.com/1718-7729/32/1/20
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1718-7729/32/1/20

Similar Items